◼ Archived
Business
🔮 fades ✓
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
1 trends tracked about this subject — the full history, oldest to newest below.
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.